We provide a full spectrum of Neuro Functional and NeuroFeedback diagnostics complimenting both the research and educational spheres because our expert software and hardware that we use is focused on the design and implementation of highly innovative, industry-leading products designed to meet the needs of researchers, consumers, educational, corporate, fitness and professional services.
Our Neuro System combines various electrophysiological biomarkers pertaining to numerous cognitive conditions. It details known clinical correlations based on over 600 scientific publications and defines electroencephalography-derived metrics, including qEEG, event-related potentials, E Loreta Source Analysis, and ECG. Recommended medical interventions are based on these clinical correlations.
Challenges in Assessing Cognitive Impairment
Cognitive impairment can occur at any age for a variety of reasons, including stress, dementia, head injuries, sleep disorders, and pain. At the primary care level, current testing lacks the sensitivity and specificity to make accurate patient assessments. Until recently, it has been difficult to objectively assess patients for cognitive impairment due to the lack of specificity.
There is an increased need for physicians to test neurocognitive function due to the aging population, the prevalence of stress and pain, and increased awareness of the impact of head injuries on cognition. Cognitive symptoms can occur outside of normal age‐associated memory loss.
When assessing a head injury, physicians must be sure to accurately assess brain function in order to avoid legal repercussions. Without proper diagnosis, a head injury can have a severe negative impact on patient outcomes.
Patients that are cognitively impaired can present symptoms such as confusion, forgetfulness, "brain fog," and functional impairment. The NeuralScan system enables the physician to quickly and objectively assess cognitive impairment in the office in order to aid in the diagnosis of causative conditions.
Importance of Early Detection
As the population ages, the prevalence and impact of cognitive impairment can have a significant effect on individuals, families, and society as a whole. A decline in cognitive abilities is now believed to be a process that occurs over 20 to 30 years, eventually leading to poor cognitive outcomes. Cognitive testing as early as the age of 45 can be beneficial.
Current paper‐based assessments used in primary care make it difficult to determine the dementia subtype, resulting in less successful treatment outcomes. As many as 86% of deceased patients suffering from dementia were misdiagnosed with Alzheimer’s disease.
The NeuralScan system can help assess patients up to 15 years prior to the onset of symptoms. Early detection of cognitive disorders allows for quicker treatment of the associated causes, such as nutritional deficiencies, stress, and thyroid problems.